1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Burosumab for treating FGF23-related hypophosphataemia in tumour-induced osteomalacia [ID3924 ]

In development [GID-TA10822] Expected publication date: TBC

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Topic selection

  • Supporting documentation MSWord 41 KB 05 September 2022  

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope post referral PDF 217 KB 17 March 2022  
  • Draft matrix post referral PDF 178 KB 20 April 2022